Hypertension, Vol 5, 629-634, Copyright © 1983 by American Heart Association
M Loudon, RF Bing, H Thurston and JD Swales
We have studied the contribution of circulating renin of renal origin to
renin-like activity within the arterial wall and to blood pressure. Bolus
injections of renin sufficient to elevate blood pressure by 44.7 mm Hg
caused aortic renin to rise from 0.13 to 1.48 ng angiotensin I/100 mg/hr in
nephrectomized rats. Elevation of aortic renin was still present at 6
hours, and this was associated with significant blood pressure elevation (p
less than 0.05) which could be reversed by infusion of sarcosine, alanine,
angiotensin II (saralasin). Prevention of the pressor effect by
pretreatment with the converting enzyme inhibitor captopril did not reduce
renin uptake. When kidneys were left in situ, although significant uptake
of renin could be demonstrated 1 hour after injection, the increase at 3
hours was no longer significant (p greater than 0.05) and blood pressure
returned to normal by 1 1/2 hours. This change in blood pressure may be
related to the much more rapid clearance of circulating renin in the
presence of normal kidneys or to other renal factors influencing the blood
pressure response. The present studies demonstrate therefore that most of
the renin-like activity within the aortic wall is derived from plasma renin
and it seems probable that this component of the renin-angiotensin system
plays an important role in blood pressure maintenance in the nephrectomized
rats injected with renin. The relationship is less obvious in the presence
of normal kidneys where additional influences may come into play.
ARTICLES
Arterial wall uptake of renal renin and blood pressure control
This article has been cited by other articles:
![]() |
E. N. Lavrentyev, A. M. Estes, and K. U. Malik Mechanism of High Glucose Induced Angiotensin II Production in Rat Vascular Smooth Muscle Cells Circ. Res., August 31, 2007; 101(5): 455 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Jan Danser, W. W. Batenburg, and J. H. M. van Esch Prorenin and the (pro)renin receptor--an update Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1288 - 1292. [Full Text] [PDF] |
||||
![]() |
A.H. J. Danser and J. Deinum Renin, Prorenin and the Putative (Pro)renin Receptor Hypertension, November 1, 2005; 46(5): 1069 - 1076. [Full Text] [PDF] |
||||
![]() |
A. J. Danser and J. Deinum Spotlight on Renin: Renin, Prorenin and the Putative (Pro)renin Receptor Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 163 - 165. [PDF] |
||||
![]() |
P. C. Almeida, V. Oliveira, J. R. Chagas, M. Meldal, M. A. Juliano, and L. Juliano Hydrolysis by Cathepsin B of Fluorescent Peptides Derived From Human Prorenin Hypertension, June 1, 2000; 35(6): 1278 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Muller, K. F. Hilgers, S. Mathews, V. Breu, W. Fischli, R. Uhlmann, and F. C. Luft Effects of Human Prorenin in Rats Transgenic for Human Angiotensinogen Hypertension, January 1, 1999; 33(1): 312 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Morgan, C. Craven, and K. Ward Human Spiral Artery Renin-Angiotensin System Hypertension, October 1, 1998; 32(4): 683 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. van Kats, A. H. J. Danser, J. R. van Meegen, L. M. A. Sassen, P. D. Verdouw, and M. A. D. H. Schalekamp Angiotensin Production by the Heart : A Quantitative Study in Pigs With the Use of Radiolabeled Angiotensin Infusions Circulation, July 7, 1998; 98(1): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Boddi, L. Poggesi, M. Coppo, N. Zarone, S. Sacchi, C. Tania, and G. G. N. Serneri Human Vascular Renin-Angiotensin System and Its Functional Changes in Relation to Different Sodium Intakes Hypertension, March 1, 1998; 31(3): 836 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Muller, W. Fischli, J.-P. Clozel, K. F. Hilgers, J. Bohlender, J. Menard, A. Busjahn, D. Ganten, and F. C. Luft Local Angiotensin II Generation in the Rat Heart : Role of Renin Uptake Circ. Res., January 23, 1998; 82(1): 13 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Hilgers, E. Bingener, C. Stumpf, D. N. Muller, R. E. Schmieder, and R. Veelken Angiotensinases Restrict Locally Generated Angiotensin II to the Blood Vessel Wall Hypertension, January 1, 1998; 31(1): 368 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shimamoto and Y. Shimamoto Lisinopril Reverses Left Ventricular Hypertrophy Through Improved Aortic Compliance Hypertension, September 1, 1996; 28(3): 457 - 463. [Abstract] [Full Text] |
||||
![]() |
D. N. Muller, K. F. Hilgers, J. Bohlender, A. Lippoldt, J. Wagner, W. Fischli, D. Ganten, J. F. E. Mann, and F. C. Luft Effects of Human Renin in the Vasculature of Rats Transgenic for Human Angiotensinogen Hypertension, August 1, 1995; 26(2): 272 - 278. [Abstract] [Full Text] |
||||
![]() |
N. Basso, M. L. Kurnjek, P. Ruiz, and M. A. Cannata Effect of EXP 3174 on Blood Pressure of Normoreninemic Renal Hypertensive Rats Hypertension, February 1, 1995; 25(2): 283 - 287. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |